Canada markets closed

Titan Pharmaceuticals, Inc. (TTNP)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
6.94+0.44 (+6.77%)
At close: 04:00PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-10,180
-5,569
-10,206
-8,776
-18,242
-
Depreciation & amortization
204
112
196
221
292
-
Stock based compensation
1,270
1,013
997
1,505
7
-
Change in working capital
1,018
-916
378
-219
1,018
-
Accounts receivable
-
-
-
-
186
744
Inventory
-331
0
187
35
287
-
Accounts Payable
255
-476
-751
-1,191
1,101
-
Other working capital
-7,690
-7,094
-8,183
-7,922
-17,743
-
Other non-cash items
3
23
452
31
482
-
Net cash provided by operating activites
-7,685
-7,092
-8,183
-7,899
-17,203
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-2
-
-23
-540
-256
Other investing activites
-
734
-
-
-
-
Net cash used for investing activites
-5
732
0
-23
-540
-
Cash flows from financing activities
Debt repayment
-
-250
0
0
-1,600
-
Common stock issued
4,980
0
4,980
8,841
11,636
-
Net cash used privided by (used for) financing activities
4,984
10,000
4,984
8,841
17,933
-
Net change in cash
-2,706
3,640
-3,199
919
190
-
Cash at beginning of period
7,418
3,133
6,332
5,413
5,223
-
Cash at end of period
4,712
6,773
3,133
6,332
5,413
-
Free Cash Flow
Operating Cash Flow
-7,685
-7,092
-8,183
-7,899
-17,203
-
Capital Expenditure
-
-2
-
-23
-540
-256
Free Cash Flow
-7,690
-7,094
-8,183
-7,922
-17,743
-